Main

In all living cells, Mg2+ is the most abundant divalent cation1. Physiologically, Mg2+ is an essential cofactor in a majority of cellular processes, involved in, for example, adenosine triphosphate (ATP) production2,3,4,5,6,7,8. Therefore, intracellular Mg2+ homeostasis is tightly regulated by membrane protein Mg2+ channels and transporters2,9,10. In human, dysregulation of the Mg2+ levels is linked to a variety of diseases11,12. In eukaryotic cells, mitochondria represent the dominant compartment for production of energy in the form of ATP, a process requiring Mg2+ as a cofactor, and the nucleotide also generally forms complexes with this cation in cells13.

The mitochondrial inner membrane protein Mrs2 (mitochondrial RNA-splicing protein 2) is responsible for regulating the Mg2+ concentrations of mitochondria in eukaryotes, providing controlled uptake of the ion14,15,16. Orchestration of the Mrs2-associated flux is critical, as upregulated expression of Mrs2 causes the Mg2+ levels in mitochondria to elevate, which represents a hallmark of several types of cancers17. Conversely, deletion of Mrs2 eliminates Mg2+ permeation into the matrix, resulting in abnormal mitochondrial function and cell death15.

Mrs2 belongs to a superfamily of Mg2+ channel-forming proteins known as CorA (because of mutants exhibiting Co2+ resistance18,19,20) in prokaryotes and as Mrs2 in eukaryotes. The most well-studied members are of prokaryotic origin, which provide the cellular import of certain divalent ions such as Mg2+ (refs. 18,19,20,21). Yet, CorA and Mrs2 are known to complement each other in eukaryotes and prokaryotes, respectively22,23. CorA/Mrs2 forms homopentamers with two transmembrane (TM) helices (TM1 and TM2) in each monomer, which are preceded by a soluble N-terminal domain (NTD) that regulates the Mg2+ passage (Fig. 1a)24,25,26,27. The protein family exposes only the loop between TM1 and TM2 to the surrounding environment but this stretch harbors a conserved selective filter GMN motif that is essential for permeation25,28,29,30,31. While it appears as if different residues in the pore establish restriction to orchestrate Mg2+ conductance in CorA and Mrs2 (refs. 24,25,30,31,32,33), respectively, it is still poorly understood how the protein family operates at the molecular level. Proposed opening models for CorA include an iris-like widening of the channel upon Mg2+ binding to the regulatory domain26,34 and exchange of the pore-lining amino acids to hydrophilic residues through rotation of the stalk25,27, respectively. Notably, such gating processes are dependent on major conformational changes between closed, symmetric and open, asymmetric states in the presence and absence of Mg2+, respectively31,35,36,37.

Fig. 1: Overall architecture of Mrs2 and the closed conformation.
figure 1

a, Topology of one Mrs2 monomer, with the NTD located in the matrix and TM1 and TM2 in the C terminus. The conserved GMN selective filter motif is located at the end of TM1 and two acidic residues (red dots) in the loop connecting TM1 and TM2. b, SEC profile of detergent-solubilized GFP-fused CtMrs2 (performed at least five independent times) and associated Coomassie-stained native PAGE (performed twice independently), indicating that CtMrs2 forms homopentamers. c, The 2.7-Å overall resolution cryo-EM density of the closed CtMrs2 homopentamer, shown from the membrane plane, from the intermembrane space and from the matrix (C5 map). Separate monomers are colored blue, orange, wheat, green and pink and the nanodisc is colored gray. d, Cartoon representation of the final structure of the closed CtMrs2 homopentamer with the same views and colors as in c. e, Surface electrostatics of the closed CtMrs2 homopentamer, shown from the membrane plane, from the intermembrane space and from the matrix.

Source data

Apart from studies of isolated domains38, the available CorA/Mrs2 structural information is limited to nonconducting structures of prokaryotic TmCorA24,30,31,32,33 from Thermotoga maritima, MjCorA25 from Methanocaldococcus jannaschii and human Mrs2 (hMrs2)39,40. Moreover, low-resolution structural information is available for TmCorA, suggesting an opening through an asymmetric conformation. Consequently, several considerable research gaps remain in the field. Most notably, the molecular principles that govern permeation, gating and regulation remain enigmatic, particularly for Mrs2 proteins but also for CorA. This is further underscored by the available conflicting opening models for CorA and the relatively low sequence homology between Mrs2 and CorA proteins and even among Mrs2 members.

Herein, we provide results that shed further light on the Mg2+ uptake and regulation of Mrs2.

Results

Functional characterization and overall architecture of Mrs2

Reduced growth on nonfermentable carbon sources represents a classical phenotype of eukaryotic cells lacking Mrs2 (ref. 38). We reproduced this observation through experiments using an in vivo assay based on wild-type (WT) and MRS2-knockout Saccharomyces cerevisiae strains (Extended Data Fig. 1a). To further dissect the function of the Mrs2 proteins, we selected a member from Chaetomium thermophilum, CtMrs2 (UniProt G0S186), which shares 30% and 43% sequence identity to hMrs2 and ScMrs2, respectively (Extended Data Fig. 2). First, we assessed the cellular localization in S.cerevisiae cells of a conservatively truncated CtMrs2 form fused to green fluorescent protein (GFP) to the N terminus. As observed from the bioimaging of live cells, the protein is targeted to internal compartments (Extended Data Fig. 1b), consistent with localization to mitochondria. Furthermore, the purified GFP-fused CtMrs2 protein sample displayed the expected homopentameric state following size-exclusion chromatography (SEC) and on blue native page (Fig. 1b). Thus, our data suggest that CtMrs2 serves as a Mg2+-conducting homopentameric channel resident in mitochondria like other Mrs2 members.

To further illuminate the structure and function of Mrs2 channels, the purified CtMrs2 sample was reconstituted into nanodiscs to facilitate single-particle cryo-electron microscopy (cryo-EM) (Methods). We first maintained Mg2+ in all procedures during sample preparation. Cryo-EM micrographs of the sample showed well-distributed particles, with the corresponding two-dimensional (2D) classifications demonstrating features of a soluble and a TM domain, respectively (Extended Data Fig. 3). The final reconstructed map reached an average resolution of 3.1 Å in the absence of imposed symmetry (Table 1). Upon map inspection, we also obtained a complementary map determined at 2.7-Å overall resolution when C5 symmetry was applied, in accordance with the established five-fold assembly of CorA/Mrs2 proteins31. The TM and soluble domains are overall well resolved in the C5 map, both consistent with five intermixed monomers, enabling de novo building of the polypeptide chains (Fig. 1c,d, Extended Data Figs. 3 and 4 and Supplementary Fig. 1a). The CtMrs2 architecture exhibits a similar cone-shaped fold to the prokaryotic CorA proteins (root-mean-square deviation (r.m.s.d.) of 3.4 Å to Protein Data Bank (PDB) 3JCF; alignments were performed using secondary-structure matching in Coot throughout the manuscript)24,25,30,31,32,33. Moreover, the structure shows an even higher resemblance to the structure of hMrs2 (r.m.s.d. of 3.8 Å to PDB 8IP3) (Extended Data Fig. 5)39,40,41. Accordingly, the membrane-spanning domain comprises two helices from each monomer. TM1 (residues 416–441) helices establish an inner ring ~30 Å across the mitochondrial inner membrane, surrounding the pore that is vertical to the membrane. TM1 helices also form a funnel extending ~100 Å into the matrix (sometimes referred to as the stalk helix, residues 371–440), while TM2 (residues 451–483) helices form an outer ring, wrapping around the TM1 helices. Because the TM1 helices are twisted (approximately 20° compared to TM2 helices), the TM2 helices interact with two TM1 helices, one within the monomer and the other in the adjacent polypeptide. Conversely, the NTD harbors six antiparallel β-sheets (β1–β6) and eight helices (α1–α8) (Fig. 1c,d and Extended Data Fig. 1c,d). Helices α4 and α5 (also known as willow helices) are parallel to the stalk helix, forming an acidic ring adjacent to the membrane interface through a range of negatively charged residues (Fig. 1e and Extended Data Fig. 1e). Adjacent to this acidic region, a basic ring is formed by positively charged residues of TM1 (K422) and the C terminus. The structure also exhibits an electronegative entry mouth from the intermembrane space (Fig. 1e), which may have a role in attracting hydrated Mg2+ from the surrounding environment. This region is established by the loop in between TM1 and TM2, which is possibly partly integrated in the mitochondrial inner membrane (Fig. 1c,d). Similarly, the inside of the funnel in the matrix is also highly negatively charged (Fig. 1e). These surface charge features are also preserved overall in hMrs2 (refs. 39,40,41).

Table 1 Cryo-EM data collection, refinement and validation statistics

A closed configuration with multiple bound Mg2+ ions

While the ion permeation pore overlays with that of the CorA proteins, it is substantially longer in CtMrs2, stretching ~70 Å across the mitochondrial inner membrane and remaining narrow a further ~5 Å into the matrix, limited by the five TM1 or stalk helices throughout (Fig. 2a,b and Extended Data Fig. 6). The channel starts at the negatively charged entrance in the intermembrane space and ends where the funnel commences to widen, stretching from N443 to R406, as also visualized using the MOLE online server42 and HOLE software analysis43 (Fig. 2a,b). This pore harbors four strong nonproteinaceous features in the cryo-EM density assigned as Mg2+ ions, as supported by similar observations for certain of the sites in hMrs2, also in nonsymmetric C1 maps39,40 (Fig. 2c,d and Extended Data Fig. 7).

Fig. 2: The closed permeation pathway and Mg2+-binding sites.
figure 2

One selected monomer is shown in orange throughout. a, MOLE software analysis of the conducting pore, shown as electrostatic surface, with residues lining the pathway shown as sticks. b, HOLE software calculation of pore diameter along the pore. c, Location of putative Mg2+ ions (shown in green) in the closed homopentamer. d, Close-up views with supporting cryo-EM density in the symmetry-applied C5 map of the putative Mg2+-binding sites close to or in the conducting pathway. Site U is positioned next to the loop in between TM1 and TM2 and site S is positioned next to the GMN motif of the selectivity filter. Sites P1 and P2 are located in the TM domain. e, Close-up views of sites M1–M4 in the NTD of CtMrs2. f, Close-up views of the corresponding Mg2+-binding sites (shown in e) in hMrs2 (PDB 8IP3), equivalent to sites M1 (top) and M4 (bottom). g, Growth phenotypes on YPD and YPG (the latter requiring mitochondrial respiration) media of WT Mrs2 from S.cerevisiae (ScMrs2), the equivalent MRS2-knockout strain (−MRS2), and cells based on −MRS2 with an empty vector or a vector containing different mutant forms of ScMrs2 (CtMrs2 numbering).

The first Mg2+ is bound by the loops connecting TM1 and TM2, interacting with the conserved N443 (of the GMN motif), E449 and perhaps E450. This is relevant as it has been shown that this region is important for the Mg2+ conductance of CorA and Mrs2 proteins5,44. Indeed, N443 and E449 are omnipresent within the CorA/Mrs2 family and E450 is also conserved among Mrs2 (Extended Data Figs. 2 and 5a). We propose that E449 and E450 are responsible for the initial uptake of fully hydrated Mg2+ (with a diameter of 9.5 Å)1, as permitted by the 10.6-Å and 17.8-Å diameters of the pores at these residues (pore calculations were computed using the software HOLE throughout the manuscript), respectively, a hypothesis also supported by previous efforts on hMrs2 (ref. 5). This arrangement may prime hydrated Mg2+ for the pore, thereby augmenting the local concentration before uptake, and contribute to establishing specificity. We coin this site U, as it likely is important for the uptake of partially dehydrated Mg2+, considering the 4.6-Å distance to N443. Directly associated, a second Mg2+ ion is coordinated to the main and side chains of GMN motif residues G441 and N443, respectively (Fig. 2c,d and Extended Data Fig. 7). The narrow width of the pore (~4.5-Å diameter at both G441 and N443) suggests that the ion is further dehydrated, as previously reported for this site of TmCorA31,32,33 and hMrs2 (ref. 39); thus, Mg2+ is partially water-stripped during the delivery from site U. Further supporting a critical role of the second site, it is generally found in CorA and Mrs2 structures, including hMrs2 (we name this site S for specificity, as discussed later)31,32,33,39.

Finally, two additional features of the cryo-EM density in the pore are assigned as Mg2+ ions, the first located at T434 (glycine in hMrs2) and the second positioned at the conserved T427 (Fig. 2c,d and Extended Data Fig. 7). We designate these pore sites P1 and P2; because of the narrow pore diameters of 5.3 and 7.4 Å, respectively, it is likely that the ions at these sites are only partially hydrated.

Three more constriction regions of the pore follow P2, marked by D420 (asparagine in hMrs2), the conserved M417–R413 pair that is positioned at the membrane interface to the matrix and the R406 (phenylalanine in hMrs2)–D410 (invariant) pair. Yet, we do not observe cryo-EM density for ions at these three constrictions. However, on the basis of the hMrs2 structures, the presence of Cl and Mg2+ was suggested at the equivalent of R413 and D410, respectively39,40. Nonetheless, the combination of invariant positively charged residues at R413 and a hydrophobic or positively charged lock for cations at R406, along with the small diameters at these constrictions (4.0 and 2.0 Å, respectively, representing the narrowest parts of the permeation pathway), indicates that the CtMrs2 structure is closed (Fig. 2b).

Intermonomer Mg2+ binding to the soluble domain

The cryo-EM density reveals the presence of four more putative Mg2+-binding sites per monomer, present as a ‘glue’ in between separate polypeptides in the soluble fraction of CtMrs2. One pair of these sites (M1 and M2; M for the matrix of the mitochondria) are positioned at the tip of the protein (Fig. 2c,e and Extended Data Fig. 7). M1 is tightly coordinated by E374 and E378 of the stalk helix of one monomer and linked to D349 and D350 next to α5 of the adjacent monomer (Fig. 2c,e and Extended Data Fig. 7). Notably, this site is essentially conserved in hMrs2 as E293, E297 and E261 (Fig. 2f). Similarly, M2 interacts with H370 and the conserved E374 and loosely binds to the conserved D349 of the neighboring protein chain (Fig. 2c,e and Extended Data Fig. 7). M2 may also exist in hMrs2 as E262 and E293 or E261 and E263 but this is not supported by the hMrs2 structures39,40,41. We conclude that the approximate position of M1 likely is conserved, although the binding amino acids vary somewhat among Mrs2 members. Divergent to the Mg2+ sites at the funnel tip in CorA proteins, M1 and M2 are located inside the negatively charged funnel, which may imply a somewhat different role of these sites (or rather M1) in Mrs2 proteins than the corresponding in CorA proteins (Extended Data Fig. 6c).

The second pair of putative Mg2+-binding sites (here denoted M3 and M4) are located in between the stalk helix of one monomer and helix α5 of the adjacent monomer (Fig. 2c,e and Extended Data Fig. 7). M3 and M4 are positioned deeper into the funnel than M1 and M2, closer to the pore end. M3 is coordinated by S396 and S397 of the stalk helix and K325, S328 and T329 (through the side chains for all except the lysine) in the α5 helix of the neighboring monomer. Conversely, the directly associated M4 interacts with N393 and S396 of the stalk helix and S328, T329 and Q332 of helix α5 of the adjacent protein chain (Fig. 2c,e and Extended Data Fig. 7). Interestingly, T329 and N393 are conserved as glutamates in many Mrs2 members including hMrs2. Moreover, despite being positioned somewhat more peripherally, M4 is maintained in hMrs2, bound by the conserved E312 of the stalk helix and E138, E243 and D247 of helix α5 (Fig. 2f)39. Similarly, sites M3 and M4 are also conserved in certain but not all CorA members, such as MjCorA (PDB 4EV6)25 (Extended Data Fig. 5d). Thus, in addition to site M1, it is likely that the approximate location of site M4 is maintained across Mrs2 proteins (subtle differences observed even among hMrs2 structures, sometimes involving T246)40 and that M4 is also present in many CorA members. It is possible that the highly electronegative environment of the funnel serves to ensure that these cation sites are occupied when the Mg2+ levels in the matrix are elevated (Fig. 1e).

On the functional role of the Mg2+-binding residues

To further investigate Mg2+ binding, conductance and regulation, we exploited the previously mentioned S.cerevisiae-based assay, assessing the WT and mutant forms of ScMrs2 with maintained expression profiles (Extended Data Figs. 5a and 8 and Supplementary Fig. 1b). Supporting a role in ion uptake and permeation for site U, growth on a nonfermentable carbon source was impaired with the E449K;E450K double substitution (Fig. 2g). Similarly, the G441A;M442A;N443A mutant exhibited reduced cell proliferation, which is consistent with previous studies demonstrating that interruptions of the GMN motif impair the protein function23,44,45,46. Surprisingly, substitutions targeting sites P1 and P2 (T434A and T427A, respectively) left the cells essentially unaffected. Our interpretation of this observation is that certain parts of the ion conductance pathway are somewhat insensitive to amino acid changes, as also supported by the fact that T434 is replaced by a glycine in hMrs2 (Extended Data Figs. 2 and 5a). Conversely, the cell growth was abolished when selected, putative, gating residues of the pore were substituted (M417A, N412A;R413A and D410A), indicating a crucial role of these amino acids for protein function (Fig. 2g). However, substitution of two of the residues contributing to the M1 and M2 sites (E374A;E378A) left the cell proliferation unaffected. This can be interpreted as the latter form having little consequence on protein function, as discussed later.

The open state

While not evident from the previously available structures of CorA/Mrs2, Mrs2 must open for Mg2+ influx when the levels of the cation are low. Consequently, to further illuminate the Mg2+ conductance mechanism, we prepared a new CtMrs2 sample using a mild isolation strategy with the inclusion of EDTA from cell lysis and until final usage. Two cryo-EM maps, with and without applied C5 symmetry, were determined at an overall resolution of 3.2 and 3.5 Å, respectively (Extended Data Fig. 9 and Methods). However, the two maps superpose well, yielding a single structure (Fig. 3a, Extended Data Fig. 10 and Table 1).

Fig. 3: The open state of Mrs2.
figure 3

The cryo-EM density panels refer to the C5 map throughout. a, Left, the 3.2-Å overall resolution cryo-EM density of the CtMrs2 homopentamer open state. Right, cartoon representation of the corresponding structure. The inset shows the feature assigned as cardiolipin, with the equivalent cryo-EM density in gray. b, Surface electrostatics of the open structure shown from the membrane plane, from the intermembrane space and from the matrix. cf, Structural comparisons of the open and closed CtMrs2 structures along the ion conductance pore at E449-E450 (c; view from the intermembrane space), D420 (d; view from the matrix), M417 (e; view from the intermembrane space) and R413 and R406 (f; view from the intermembrane space). g,h, MOLE and HOLE software analyses of the pore of the open structure, shown as the electrostatic surface, with residues lining the pathway shown as sticks (g) and with the diameter of the pore along the pathway (h). i, Close-up views of the RDLR motif and the R314 wedge in the open structure. j, Putative Mg2+-binding sites at the GMN motif selectivity filter (S site) and at the T427 (P1) and T434 (P2) rings observed in the cryo-EM maps calculated with five-fold symmetry (left) and without symmetry (right). k, Mg2+-binding stoichiometry in various CtMrs2 forms under different conditions, as determined by ICP-MS (stoichiometries refer to Mg2+ per CtMrs2 pentamer). Data points represent the means of five independent measurements, each from one purified sample, and error bars indicate the s.d.

Source data

The EDTA-induced structure preserves the homopentamer form (Fig. 3a and Extended Data Fig. 10). Indeed, the TM domain including the pore is well maintained overall and the intermembrane space remains negatively charged, presumably facilitating Mg2+ uptake (Fig. 3b–d). However, as partly achieved by rotation of these side chains away from the center (discussed below), the constriction rings of the pore marked by D420, M417–R413 and R406 in the closed structure display a striking enlargement of about 1, 5 and 13 Å (Fig. 3d–f). As a consequence, site S at the GMN motif is the narrowest point of the pore (4.0–4.7 Å in diameter) in the open structure. Lastly, the funnel on the matrix side of the membrane is also widened. Thus, we conclude that this structure represents a conducting conformation, allowing the influx of partially hydrated Mg2+ to the matrix (Fig. 3c,g,h).

Few intermonomer contacts remain in the funnel of the open structure. However, while the conserved R314 has a peripheral orientation in the closed configuration, it serves as a wedge in between two adjacent stalk helices in the open conformation, through interaction with the invariant D410 and N414 of the neighboring monomer, thus directly influencing the matrix-facing end of the conducting pathway (Fig. 3a,i). Furthermore, toward the funnel tip, residues R200 and R203 of the conserved RDLR motif of the α1–α3 subdomain interact with E346, D348, E374 and E378 of the stalk helix of the adjacent monomer (side chain interactions except for E346), residues that assist in establishing the M1 and M2 sites in the closed structure (Fig. 3a,i). It is, thus, tempting to speculate that sites M1 and M4 (and sites M2 and M3 in CtMrs2) stabilize the closed state, while the RDLR site serves the same purpose in the open conformation. However, the RDLR motif is only present in the eukaryotic Mrs2 proteins, implying that this interaction is specific for the eukaryotic members.

Interestingly, while we expected a Mg2+-depleted structure, we observed cryo-EM density at the S, P1 and P2 sites, which we tentatively assigned as Mg2+ despite the EDTA treatment of the sample (the P2 site is not as distinct as the other sites in the map calculated without imposed symmetry) (Fig. 3j). To confirm whether Mg2+ was still present in the presence of chelator, we determined Mg2+ binding stoichiometries to CtMrs2 using inductively coupled plasma mass spectrometry (ICP-MS). The results show that Mg2+ was indeed present in the sample subjected to EDTA (Fig. 3k). Surprisingly, we detected a similar Mg2+-to-protein ratio for all samples (Mg2+-treated sample, EDTA-treated sample and two separate double mutants targeting sites M3 and M4, respectively), equivalent to ~2 Mg2+ ions per CtMrs2 pentamer as observed in the open structure (Fig. 3k). This indicates that CtMrs2 adopts an open conformation in the absence of Mg2+, as we had to remove Mg2+ in the last step of purification for the ICP-MS analyses. Considering that site S is formed by the hallmark GMN motif of the CorA/Mrs2 proteins, it is conceivable that its presence in the open configuration relates to an important role in establishing Mg2+ specificity and perhaps also in preventing the (back)flow of Mg2+, other ions or even water molecules from the matrix.

Conformational changes between the closed and open states

In comparison to the TM domain, dramatic differences occur in the soluble domains between the closed and open structures. Overall, as seen from the mitochondrial matrix side, the soluble domains rotate counterclockwise and widen from the closed to the open structure, with accentuating changes from the start (linked to the pore) to the end (at the tip) of the funnel (Fig. 4a,b).

Fig. 4: Conformational changes between the open and the closed states.
figure 4

a,b, Alignments of the TM domains of the open and closed CtMrs2 structures shown from the membrane plane, from the intermembrane space and from the matrix (a) and of a single monomer (b). Residues lining the pore are shown as sticks in b. The intermembrane space loop and the TM domain (formed by TM1 and TM2) are highly similar between the two states, whereas the NTD is rotated, providing a wider funnel in the open structure. Nonetheless, the five-fold symmetry is maintained in both configurations. c,d, Conformational changes at the M1 and M2 (c) and M3 and M4 (d) Mg2+ ion-binding sites between the closed (left) and the open (right) states, with residues involved in ion binding shown as sticks.

Remarkably, among the most displaced structural features are the stalk and α5 helices of adjacent monomers, which are well separated in the open Mrs2 setting, thus eliminating the M1–M4 sites. Specifically, the residues forming the M1 and M2 sites are separated by more than 20 Å in the open structure (Fig. 4c). Similarly, the amino acids that bind to sites M3 and M4 are displaced by approximately 10 Å (Fig. 4d). The consequence is that the stalk helix is straightened and shifted outward in the open structure, thereby being mainly responsible for the widening of the D420, M417–R413 and R406 constrictions of the pore. Moreover, the stalk helix preceding the soluble domain (the α1–α3 subdomain) within the monomer is brought along from a funnel-lining to a more peripheral position. Notably, this greatly reduces contacts between monomers in the funnel in the open configuration, with the RDLR arginines essentially replacing the M1 site in the closed structure.

The M1–M4 Mg2+ site regions control the shape and conductance of Mrs2

Considering the dramatic rearrangements of the M1–M4 ion-binding regions between the two configurations, we aimed to further refine the roles of these sites. First, we used an Escherichia coli-based Ni2+ sensitivity assay, which has been exploited, for example, for studies of hMrs2 (ref. 40), assessing Mrs2-faciliated increased uptake of the metal. As expected, E.coli cells expressing CtMrs2 showed increased sensitivity toward Ni2+ compared to control cells and the toxicity could be prevented through the N443A substitution that interferes with the GMN selectivity filter (Fig. 5a). Conversely, disruption of the M1 and M2 (E374A;E378A) or the M3 and M4 (S328A;T329A and S396A;S397A) sites increases cell toxicity (the same mutants were applied in all below-mentioned assays). This suggests that such forms correlate with open CtMrs2. Instead, an intention to stabilize the M1 and M2 sites (E374R, mimicking bound Mg2+) resulted in decreased Ni2+ sensitivity, congruent with closed Mrs2. Interestingly, supplementation of Mg2+ partially rescued all protein forms, indicating that CtMrs2 has higher affinity for Mg2+ than for Ni2+ and further illustrating that the M1–M4 Mg2+-binding sites have an important mechanistic role (Fig. 5a,b).

Fig. 5: The roles of the M1–M4 Mg2+-binding sites.
figure 5

a,b, Comparison of the growth of E.coli with different CtMrs2 forms at different ion concentrations. The empty vector represents a control without Mrs2. c, Overlay of representative Mg2+ currents recorded in oocytes expressing WT and mutants. The red bar indicates the application period of Mg2+-containing recording solution. The control denotes water-injected oocytes. d, Summary of the recorded currents with peak current amplitudes following Mg2+ perfusion (Ipeak; left) and spontaneous current decay during Mg2+ perfusion (ΔIamp (%); right). Data shown as the mean ± s.e.m. (n = 5–19). Statistical analysis was conducted using a one-way ANOVA followed by Dunnett’s multiple-comparisons test in comparison to WT. NS, nonsignificant (P > 0.05; 0.16 for S328A-T329A and 0.79 for S396A-S397A); **P = 0.0036 and ****P < 0.0001. Further data and details are provided in Supplementary Fig. 2 and the Methods. ND, not determined (because of no detectable currents). e, Limited proteolysis assay (performed twice independently) using purified CtMrs2 forms using two separate proteases. The bands above 30 kDa represent CtMrs2, while the bands between 25 and 30 kDa are GFP, as confirmed by mass spectrometry. f, Binding isotherms for Mg2+ binding to WT CtMrs2 (at two stock concentrations) and mutant forms showing the heat of injection as a function of the molar ratio between Mg2+ and CtMrs2 monomer. For all mutants, 50 mM Mg2+ was used. For the mutants, the presented values are the means of two independent ITC titrations. Error bars show one s.d. and are estimated from the baseline uncertainties provided by NITPIC as previously described54 and from the uncertainty between injection from the two datasets, where i refers to the injection number (1–19). The inset graph shows the raw thermogram, before integration by NITPIC, for the titration of 50 mM Mg2+ into WT. The complete ITC data are presented in Supplementary Fig. 4 (Methods).

Source data

To further dissect the conductance, we performed electrophysiological recordings of CtMrs2 and mutants, which were expressed in Xenopus oocytes and perfused extracellularly with Mg2+ solution, guided by previous studies41,46 (Fig. 5c,d and Supplementary Fig. 2). The results show that WT displayed clear inward currents that peaked within seconds of the supplementation of Mg2+ and decayed slowly, reaching ~40% of the peak current by the end of the 2-min period that Mg2+ was supplied. In contrast, no current was observed for the N443A form or in water-injected oocytes (control). Moreover, the inward currents were rapidly abolished upon return to a Mg2+-free extracellular solution and were significantly reduced in the presence of the established inhibitor cobalt hexammine, all supporting that the CtMrs2 protein mediates the Mg2+ influx. In agreement with the Ni2+ sensitivity assay, significantly larger inward currents were detected for the ion-binding interfering forms (M1–M2 and M3–M4), which were even more pronounced for the M3–M4 mutants, in accordance with these amino acid changes favoring the open state. In comparison, no current was detected for the E374R mutant, supporting that this form prefers the closed conformation. Conversely, the decay of the flux during the 2-min Mg2+ exposure was similar for WT and for the M3–M4 alanine substitutions but the conductance was better maintained for the M1–M2 alanine mutant.

Next, we set up a limited proteolysis assay using purified protein. All the purified CtMrs2 forms maintained the pentameric assembly as assessed by SEC and all samples were susceptible to proteases (trypsin or chymotrypsin) at low Mg2+ concentrations (Fig. 5e and Supplementary Fig. 3). However, at elevated Mg2+ levels, WT and the two M3–M4 site mutants preserved protease resistance (less so for the S328A;T329A form). Conversely, the two M1–M2 substitutions (E374A;E378A and E374R) displayed almost complete susceptibility to protease degradation in the presence of Mg2+ (some uncleaved CtMrs2 left with trypsin for E374R). This indicates that the open state is more vulnerable for cleavage and that the two M3–M4 mutant forms can shift from the open to the closed configuration when Mg2+ is supplemented, whereas the M1–M2 alanine substitution may not.

Lastly, we conducted isothermal titration calorimetry (ITC) measurements to detect Mg2+ binding to purified CtMrs2 (Fig. 5f and Supplementary Fig. 4). The binding isotherms were recorded by titration of Mg2+ into the protein, starting with conditions under which an open protein conformation is expected. The binding isotherms of WT were approximately biphasic, reflecting multiple binding events upon the addition of Mg2+, as seen for other metal-binding proteins47. The first observed binding event was endothermic, while the second binding event was exothermic (Fig. 5f, inset, and Supplementary Fig. 4). However, both phases were dominated by the large exothermic contribution (negative peaks) of the second binding event. These findings are consistent with a sequential binding model with high positive cooperativity between two sets of binding sites48,49; the first binding event is endothermic and has the lowest affinity for the ligand, whereas the second binding event is exothermic and has the highest ligand affinity. We interpret the endothermic binding event to originate from Mg2+ binding tightly coupled to conformational changes from the open to the closed state. This structural shift then renders Mrs2 in a Mg2+-binding competent state where the ions are bound through an exothermic binding event to the M3 and M4 sites. The later reaction is associated with a large negative enthalpy change (ΔH) that dominates the ITC signal. Detailed quantitative analysis of the binding isotherms remains difficult because of the complex binding model originating from multiple unique binding sites and the conformation sensitivity of the system, together with the relative sparse amount of data points in the binding isotherms50,51,52,53.

To further confirm this interpretation, we measured the equivalent Mg2+ binding to the abovementioned CtMrs2 M1–M2 and M3–M4 site variants. Notably, the M1–M2 site forms displayed considerable different binding isotherms compared to WT and the M3–M4 mutants. The lack of signal for the E374R substitution supports the notion that the M1–M2 binding site in the E374R variant is occupied by the arginine sidechain. However, the E374R variant, despite favoring the closed state, appeared to also leave the M3–M4 sites in a binding-incompetent state. Similarly, binding of Mg2+ to the E374A;E378A variant was also significantly altered compared to the WT, presumably preventing the formation of the closed state. Conversely, disruption of the M3 and M4 sites (S328A;T329A and S396A;S397A, respectively) still permitted Mg2+ binding. The effect on the binding isotherms was a shift of the minimum to higher molar ratios (more Mg2+ required) and a decrease in the binding enthalpy (Fig. 5f). These effects are again consistent with a sequential binding model with high cooperativity between two sets of sites (M1–M2 and M3–M4), where Mg2+ binding to sites M3 and M4 only takes place after Mg2+ binding to sites M1 and M2 and where the introduced substitutions weaken the affinity of sites M3 and M4 to Mg2+. The observed change in signal from the M3–M4 variants (decrease in the binding enthalpies, ΔH) is expected when the affinity for the ligand is lowered because of the substitution.

Collectively, this functional characterization points toward the M1–M2 site region being decisive for determining the CtMrs2 conformation, providing a closed state when Mg2+ is bound (as mimicked by E374R; an exception is discussed below) and an open configuration when the ions are not present (ion binding prevented by the M1–M2 alanine substitutions), as observed in our structures. The functional assays identify that a relatively high Mg2+ concentration (in the micromolar range) induce the conformational changes. The role of the M3 and M4 sites appears to be less dramatic; however, on the basis of the abovementioned assays, they are clearly important at least for the regulatory function of CtMrs2.

Discussion

Herein, we propose a Mg2+ auto-ligand-regulated permeation mechanism (Fig. 6). Fully hydrated Mg2+ from the intermembrane space is attracted and concentrated by two layers of negatively charged residues (E449 and E450) in the pentamer. Furthermore, E449 forms the inner ring and N443 may be involved in Mg2+ dehydration ion at site U. Next, the ion is transferred to site S, which represents the narrowest point of the open channel where specificity is established by the GMN motif, as supported by inactivating substitutions (Figs. 2g and 5). Nevertheless, the site is continuously present in the open and closed structures; thus, a role in also preventing (back)flow cannot be excluded. The passage of partially hydrated Mg2+ is then facilitated by hydrophilic main and/or side chains, including the conserved T427. Next, ion exit to the matrix is orchestrated by gating residues (in particular, R413 and M417), which in turn are controlled by the soluble domains.

Fig. 6: Proposed Mg2+ autoregulation gating mechanism of Mrs2.
figure 6

a,b, Schematic model as viewed from the mitochondrial inner membrane (a; with two monomers for simplicity) and from the matrix (b). In the closed state, Mg2+ ions bind between the NTDs of separate monomers (positions M1 and M4 or M1–M4 in CtMrs2), thereby assisting in stabilizing the symmetrical shape, and to distinct positions of the pore (U, S, P1 and P2). In the open configuration, Mg2+ is only present at some of the pore sites (S, P1 and P2) and the NTD is instead maintained in an alternative symmetrical assembly by the RDLR motif and residues that previously formed the M1 and M2 sites (blue). At elevated Mg2+ levels in the mitochondrial matrix, Mrs2 is closed. Acidic rings formed by the loops in the intermembrane space (shown in red) attract fully hydrated Mg2+ (large green circles), which can be transferred as partially hydrated Mg2+ (small green circles) to the asparagine ring of the GMN motif selectivity filter (pink) and then to the P1 and P2 sites (purple) of the pore in the TM domain. However, flux is not permitted as the pore-gating methionine and arginine rings (brown polygons), located approximately at the membrane interface to the matrix, are closed. At low Mg2+ concentrations in the matrix, the open structure is present. Removal of the ions from M1 and M4 (and from M1–M2 and M3–M4 in CtMrs2) of the closed structure triggers a shift and rotation of the stalk helix (light brown), resulting in opening of the pore gate, which permits Mg2+ influx into the matrix. It is possible that site S also prevents backflow to the intermembrane space. The closed state is reobtained through Mg2+ destabilization of the RDLR motif interaction and through Mg2+ bridging of the separated residues of the M3–M4 site.

At elevated Mg2+ concentrations in the matrix, Mrs2 is stabilized in a closed configuration through Mg2+ that bridges the monomers, two of which (sites M1 and M4) are conserved in Mrs2, including hMrs2. Conversely, under Mg2+-depleted conditions, the two arginines of the RDLR motif and R314 serve to principally replace the M1–M2 and M3–M4 sites as a glue between monomers This stabilizes an alternative configuration of monomer–monomer interactions as observed in the open state and yet maintains the five-fold symmetry. Consequently, it is appealing to suggest that reduced levels of Mg2+ in the matrix strip the ions from the M1 and M4 sites (or M1–M4 in in CtMrs2), which is followed by the open configuration in the absence of Mg2+, in which the monomers are more separated, a transition that is unlikely to occur before the Mg2+ at M1 (or M1 and M2 in CtMrs2) has been liberated.

How is then the open state closed when the Mg2+ levels rise? We propose that Mg2+ is also key for this transition, disturbing the RDLR interaction, reforming the M1 site (M1 and M2 sites in CtMrs2) and eventually bridging the separated M4 site (M3 and M4 sites in CtMrs2) as a fully hydrated ion, thereby also displacing R314. Such a mechanism likely depends on the M1 site (M1 and M2 in CtMrs2) and the RDLR site as on and off sensors, serving as critical motifs to stabilize the two different configurations, thereby dictating the open-to-closed shift and vice versa. Conversely, the M4 site (M3 and M4 sites in CtMrs2) likely has more of a regulatory role because of increased separation in the open structure. Such a concept would also be consistent with a possible nonsymmetrical open state of TmCorA31. CorA proteins lack sites M1 and M2 but have similar sites that are more peripheral and some CorA proteins also have an equivalent of M4; together, these sites stabilize the symmetrical closed state. Conversely, the RDLR motif is absent in CorA; hence, the open state cannot be stabilized in the symmetrical shape observed here, which may lead to a collapse of the homopentamer.

Thus, our findings collectively shed light on the molecular architecture that permits ion uptake, permeation, gating and regulation of eukaryotic Mrs2 proteins, results that unify decades of observations on the CorA/Mrs2 family of proteins and that also resonate with other Mg2+ transporter and channel protein families (Supplementary Discussion).

Methods

Gene cloning

Genomic DNA from C.thermophilum (strain DSM1495) was used as a template to amplify full-length CtMrs2 using primers 1 and 2 and inserted into the pET-22b vector using NEBbulder HiFi DNA Assembly Master mix, generating construct pET-22b-CtMrs2 introns. This form was used to remove the two introns using primers 3, 4, 5 and 6 by overlapping PCR, yielding the pET-22b-CtMrs2 construct. To enhance protein expression and purification, the gene fragment coding for residues 106–539 was subcloned into the pEMBLyex4 vector using primers 7 and 8 with a 10xHis-GFP-G4S-TEV (tobacco etch virus) tag fused to the N terminus of CtMrs2106–539, yielding the pEMBLyex4-His10-GFP-G4S-TEV-CtMrs2106–539 construct. All mutations were generated using this form as the WT. Primers are listed in Supplementary Table 1. All constructs were confirmed by sequencing.

Protein production

The PAP1500 S.cerevisiae strain was used for protein production55. The plasmid pEMBLyex4-His10-GFP-G4S-TEV-CtMrs2106539 was transformed into the S.cerevisiae strain using the lithium acetate single-stranded carrier DNA–PEG method56, plated on SD medium supplemented with 15 g L−1 agar and then incubated at 30 °C for 3 days. Next, single colonies were inoculated in 5 ml of SD medium at 30 °C for 24 h with shaking at 200 rpm. Then, the cells were spun down and transferred to 250 ml of SD medium without leucine and cultured for 24 h at 30 °C with shaking at 200 rpm. Next, 50 ml of preculture was transferred to 800 ml of expression medium and cultured at 30 °C for 24 h with shaking at 200 rpm. Then, 200 ml of induction medium was applied to the cell culture and the culture continued at 25 °C for 24 h to induce protein expression. Finally, the cells were harvested at 8,000g; the cell pellet was washed with lysis buffer and then frozen in a high-pressure homogenizer (Xpress) at −20 °C for 16 h.

SD medium: 20 g L−1 glucose, 1.9 g L−1 yeast nitrogen base, 5 g L−1 (NH4)2SO4, 60 mg L−1 leucine and 30 mg L−1 lysine.

Expression medium: 3% (v/v) glycerol, 5 g L−1 glucose, 1.9 g L−1 yeast nitrogen base, 5 g L−1 (NH4)2SO4, 1.17 g L−1 amino acid mixture with isoleucine and uracil dropout.

Induction medium: 3% (v/v) glycerol, 20 g L−1 galactose, 1.9 g L−1 yeast nitrogen base, 5 g L−1 (NH4)2SO4, 1.17 g L−1 amino acid mixture with isoleucine and uracil dropout.

Protein purification

Batches of cells were cultured and purified individually to capture different conformations. For the closed CtMrs2 state, frozen cells were disrupted using a high-pressure X-Bomb cell disrupter and resuspended to 50 mg ml−1 with lysis buffer supplemented with 5 mM MgCl2. Crude membranes were collected through initial low speed centrifugation at 4,000g to remove unbroken cells, followed by ultracentrifugation at 165,000g. The obtained membranes were solubilized at 50 mg ml−1 in buffer A supplemented with 2 mM MgCl2 and 1% (w/v) n-dodecyl-β-maltoside (DDM, Anatrace) at 18 °C for 2 h and using slow rotation of the sample. The solubilized material was collected through ultracentrifugation at 190,000g for 30 min. The protein was purified using a 5-ml Histrap immobilized metal affinity chromatography (IMAC) column (Cytiva) equilibrated with buffer A supplemented with 0.05% (w/v) DDM and 2 mM MgCl2. Following sample binding, the column was washed with 20 column volumes of buffer A supplemented with 0.05% (w/v) DDM, 2 mM MgCl2 and 60 mM imidazole to remove contaminants. The target protein was eluted with buffer A supplemented with 0.05% (w/v) DDM, 2 mM MgCl2 and 300 mM imidazole. Relevant elution fractions were concentrated and applied to a Superose 6 SEC column (Cytiva) for further purification using buffer A supplemented with 0.05% (w/v) DDM and 2 mM MgCl2. The protein purity was assessed using SDS–PAGE. The peak fractions were pooled and concentrated to around 5 mg ml−1 for downstream processing. For the open Mrs2 state, a similar procedure was applied but using 2 mM EDTA instead of Mg2+ to the buffer except during the IMAC purification (where no Mg2+ was applied for the preparation of the open state). For the samples used for the limited proteolysis assay and ITC experiments, the final SEC buffer was similar to buffer A but the pH was adjusted to 8.0.

Lysis buffer: 10 mM Tris-HCl pH 7.5, 60 mM NaCl and 10% (v/v) glycerol.

Buffer A: 50 mM HEPES–NaOH pH 7.5, 150 mM NaCl and 10% (v/v) glycerol.

Nanodisc reconstitution

MSP1D1 lacking the His-tag was purified as previously reported57,58. POPC lipids (Avanti Lipids) were prepared in 20 mM Tris-HCl pH 7.5, 100 mM NaCl and 0.5% (w/v) DDM for the nanodisc reconstitution. The purified protein was reconstituted into MSP1D1 nanodiscs with a molar ratio of 1:5:75 of CtMrs2, MSP1D1 and lipids, respectively, and 200 mg of SM2 biobeads (Bio-Rad) were used to remove detergent for protein incorporation into the nanodiscs. For the closed state of CtMrs2, the assembled nanodisc sample was purified on a Superdex 200 column (Cytiva) with buffer containing 50 mM HEPES–Na pH 7.5, 100 mM NaCl and 2 mM MgCl2 and then TEV protease was added into the corresponding pooled peak fractions before incubating for 4 h at 4 °C. The cleaved CtMrs2 disc sample lacking GFP was further polished using a second SEC purification with same buffer. The protein-containing corresponding peak fractions were pooled and concentrated to 0.9 mg ml−1 for cryo-EM grid preparation. For the open state of CtMrs2, the reconstituted sample was directly purified by SEC using a Superose 6 (Cytiva) column with running buffer containing 50 mM HEPES pH 7.5, 100 mM NaCl and 2 mM EDTA. The protein-containing peak fractions were pooled and concentrated to 8 mg ml−1 for cryo-EM grid preparation.

Cryo-EM grid preparation and data acquisition

For the closed state of CtMrs2, the CtMrs2 disc sample was incubated with an additional 10 mM MgCl2 on ice for 16 h. Then, 3 μl of purified CtMrs2 disc sample (0.9 mg ml−1) was applied to glow-discharged Quantifoil Cu R 1.2/1.3 300-mesh holey carbon grids, incubated for 3 s and blotted for 3 s at 4 °C and 100% humidity. Next, the grids were plunge-frozen into liquid ethane using a Vitrobot Mark IV. For the open state of CtMrs2, 1 mM fluorinated Fos-choline-8 was added to the purified CtMrs2 disc sample (8 mg ml−1) sample immediately before preparation of the grids. Then, 3 μl of sample was applied to glow-discharged C-flat Cu R 1.2/1.3 300-mesh holey carbon grids, with a wait time of 3 s, blot force of 0 and blot time of 3 s. The grids were plunge-frozen into liquid ethane using a FEI Vitrobot Mark III at 4 °C and 100% humidity. The cryo-EM datasets were collected at the SciLifeLab Cryo-EM facility on a FEI Titan Krios EM instrument operated at an acceleration voltage of 300 kV equipped with a K3 (Gatan) detector with an applied energy filter of 20 eV and a magnification of 105,000. The dataset of the closed state was collected while operating in super-resolution mode bin 2 with a pixel size of 0.8617 Å and a total dose of 50 e per Å2 in 40 frames with a defocus range of −0.6 µm to -2.2 µm. The dataset of the open state was collected while operating in super-resolution mode bin 2 with a pixel size of 0.8566 Å and a total dose of 50 e per Å2 in 40 frames with a defocus range of −1.0 µm to -2.2 µm.

Cryo-EM data processing

Data processing was performed using cryoSPARC59, and the movies were initially processed using path motion correction (M), followed by Patch contrast transfer function (CTF) estimation. Bad micrographs, such as those that were empty, broken or containing ice, were removed through manual inspection.

For the closed state, 583 of 832 selected micrographs were first used for the blob picking and 294,000 particles were initially picked. The particles were extracted with bin 2 and subjected to two rounds of 2D classification, resulting in 237,737 good particles. Then, 30,000 particles were used for the ab initio reconstruction, followed by heterogenous refinement with all particles, generating five classes. A second-round heterogenous refinement was performed with selected particles from classes 0 to 2, applying all five class maps, generating a map from 79,066 particles.

The selected templates from the first processing step were used for template picking based on 1,386 of 2,018 selected micrographs. A total of 1,316,900 particles were initially picked and extracted with bin 2 and then subjected to four rounds of 2D classification, resulting in 425,686 good particles. Then, 40,000 particles were used for the ab initio reconstruction, followed by heterogenous refinement with all particles, generating five classes. Four further rounds of heterogenous refinement were performed with selected particles from classes 0, 1 and 3, applying all five maps, generating a map based on 143,512 particles. Then, good particles from part 1 and part 2 were reextracted by applying local motion (M) correction. The final set of 222,578 particles and the resulting model were subjected to nonuniform refinement without imposing symmetry60. Then, CTF refinement was applied, followed by a final nonuniform refinement applying C1 or C5 symmetry, yielding two maps with an overall resolution of 3.1 Å (C1) and 2.7 Å (C5), based on a Fourier shell correlation (FSC) cutoff of 0.143. The local map resolution of 2.7 Å was estimated using cryoSPARC with an FSC cutoff of 0.143. The processing flow chart is shown in Extended Data Fig. 3.

For the open state, 200,519 particles were initially picked from 835 of 6,484 micrographs through blob picking. The particles were extracted and subjected to 2D classification to generate templates. The selected templates were used for template picking and a total of 3,058,006 particles were picked from 6,484 micrographs. Extracted particles were subjected to four rounds of 2D classification, resulting in 332,383 particles. A total of 40,000 particles were used for the ab initio reconstruction, followed by heterogenous refinement with all particles, generating five classes. A second round of heterogenous refinement was performed with selected particles from class 0 and class 4, respectively. The final set of 116,609 particles from class 0 and the resulting map were subjected to nonuniform refinement and CTF refinement without imposing symmetry. The final nonuniform refinements were performed without or with C5 symmetry, yielding two maps with overall resolutions of 3.5 Å (C1) and 3.2 Å (C5), based on an FSC cutoff of 0.143. The local map resolution of 3.2 Å was estimated using cryoSPARC with an FSC cutoff of 0.143. The processing flow chart is shown in Extended Data Fig. 8.

Model building and refinement

The CtMrs2 AlphaFold61 single-chain model (AF-G0S186-F1) (Supplementary Fig. 1a) was used as a template and initially fitted into the 2.7-Å cryo-EM density map of the closed state of CtMrs2 using USCF chimera62. Parts of the termini without visible cryo-EM density were removed in Coot63 and de novo model building of the monomer, guided by the density for bulky side chains, was conducted in Coot. The monomer model was refined using real_space_refine64 in PHENIX. The refined model was used to fit into the remaining cryo-EM density map of the remaining monomers. Several cycles of model building and adjustments in Coot and real-space refinement using real_space_refine64 in PHENIX using the sharpened 2.7-Å map were performed to obtain the final model of the closed pentamer. For the open state, the same strategy was applied by starting with the refined model of the closed state of CtMrs2 as the initial template to fit into the 3.2-Å cryo-EM density map. Next, several cycles of model building and manual adjustments were performed in Coot and refinements were conducted using real_space_refine in PHENIX using the sharpened 3.2-Å map to obtain the final model. The final model was well resolved from A162 to V482, except for residues 262–270 connecting α3 and α4, thus displaying essentially the same sequence coverage as the closed structure. Model validation was performed using MolProbity65. The figures were prepared with UCSF ChimeraX66, UCSF Chimera and PyMOL.

Yeast strains, manipulations and the complementation assay

Gene deletion was carried out through a PCR-based gene knockout strategy using hphNT1 selection antibiotic markers to generate an MRS2-deleted yeast strain. Mrs2-specific products from PCR amplification of hphNT1 were transformed into BY4741 WT yeast cells using herring sperm DNA in lithium acetate containing PEG3350 buffer. Antibiotic selection was achieved using 250 μg L−1 hygromycin B (Invitrogen). Crude DNA extracts were used for PCR confirmation of MRS2 gene deletion.

The full-length and mutation-complementary DNA of the MRS2 gene were cloned from the genome of the BY4741 strain and constructed into multiple-copy p426 vectors. All mutations and full-length constructs were generated using a PCR-based strategy. The constructed Mrs2 plasmids were transferred to MRS2-deleted yeast cells using herring sperm DNA in lithium acetate containing PEG3350 buffer.

Yeast strains included WT BY4741 cells, MRS2-deleted BY4741 cells and MRS2-deleted BY4741 cells expressing different versions of GFP-tagged ScMrs2. Yeast cells were cultured using standard YPD medium (2% v/v glucose, 1% w/v yeast extract and 2% w/v bacteriological peptone) for 16 h at 30 °C and then inoculated in fresh YPD medium and cultured to the log phase. Half of the cells were collected and lysed with HU lysis buffer at 65 °C for 20 min to extract whole-cell content and measured for plasmid expression by immunoblotting. The remaining cells at an optical density (OD) of 1 was spotted on YPD plates (2% v/v glucose, 1% w/v yeast extract, 2% w/v bacteriological peptone and 2% w/v agar) and YPG plates (2% v/v glycerol, 1% w/v yeast extract, 2% w/v bacteriological peptone and 2% w/v agar) with a gradient dilution. Following 4 days of growth at 30 °C, the plates were scanned. Mouse monoclonal antibodies to the HA eptitope (sc-7392) were purchased from Santa Cruz Biotechnology and used at 1:2,000 dilution for the experiment. Mouse monoclonal antibody to PKG1 (ab113687) was purchased from Abcam and used at 1:10,000 dilution for the experiment.

Ni2+ sensitivity assay

For the Ni2+ sensitivity assay, E.coli BL21(DE3) cells were transformed with empty pET-22b plasmid or plasmid with CtMrs2 forms. The constructs were then transformed spread on LB agar plates supplemented with a working concentration of 50 µg ml−1 ampicillin (throughout) and grown at 37 °C for 16 h. Single colonies were inoculated at 37 °C in LB medium supplemented with ampicillin for approximately 4 h until the OD of the cells reached 0.65. The cell cultures were then serially tenfold diluted with LB medium supplemented with ampicillin. Next, 6-µl drops of cells were spotted onto LB agar plates supplemented with ampicillin and IPTG (final concentration 10 µM) and the indicated amounts of Ni2+ (0 or 1.4 mM) or Mg2+ (0 or 1 mM). The plates were incubated at 37 °C for 20 h to compare the colony growth. Plates were imaged using the ChemiDoc MP Imaging System (Bio-rad).

Limited proteolysis assay

Purified WT CtMrs2 fused with GFP and mutant forms thereof were used for the assay (2 mg ml−1 stock solutions). Next, 10 µg of protein was incubated on ice or at 18 °C for 30 min with the desired amount of Mg2+ or EDTA with a final reaction volume of 12 µl. Then, 1 µl of trypsin or chymotrypsin (0.1 mg ml−1) was added to each sample, yielding an approximate molar ratio of 1:100 of protein and protease, respectively, and the reactions were incubated at 4 °C for 14 h or at 37 °C for 1 h. Then, 4 µl of loading buffer (4×) was applied to the reaction samples before incubating at 98 °C for 6 min. The samples were assessed using 12% SDS–PAGE Bis–Tris precasted gels and stained with Coomassie blue. The gels were imaged using the ChemiDoc MP Imaging System (Bio-rad).

Xenopus laevis oocyte experiments

The WT construct employed for the cryo-EM study and corresponding mutants were subcloned into the pGEM expression plasmid and all the constructs were confirmed by sequencing (Macrogen). Complementary RNA (cRNA) was prepared using the T7 mMessage mMachine transcription kit (Ambion, Invitrogen). The RNA concentration was quantified using spectrophotometry (NanoDrop 2000c; Thermo Fisher Scientific). Xenopus oocytes were surgically isolated at Linköping University. The surgical procedure of X.laevis frogs was approved by the Linköping Animal Care and Use Committee (permit no. 14515) and conforms to national and international guidelines. Isolated Xenopus oocytes were injected with 50 nl of cRNA with a concentration of 1 µg µl−1 and incubated at 8 °C for 3–5 days followed by 16 °C for 1 day in modified Barth’s solution consisting of 88 mM NaCl, 1 mM KCl, 2.4 mM NaHCO3, 0.33 mM Ca(NO3)2, 0.41 mM CaCl2, 0.82 mM MgSO4, 15 mM HEPES and 2.5 mM pyruvate, with pH set to 7.6 using NaOH. To allow for time-matched comparisons of current amplitude, WT and mutant Mrs2 were injected and incubated under identical conditions.

Two-electrode voltage clamp recordings were performed at 18 °C using a Dagan CA-1B amplifier. Pulled microelectrodes (0.4–1.5 MΩ; World Precision Instruments) were filled with 3 M KCl. Whole-cell currents were sampled using Clampex (Molecular Devices) at 5 kHz and filtered at 500 Hz. For illustrative reasons, in figures, the currents were filtered further to minimize noise from the perfusion system. The holding voltage was set to −60 mV and all recordings were performed with the membrane potential clamped at −60 mV. Oocytes were initially perfused extracellularly with a Mg2+-free control solution containing 100 mM N-methyl-d-glucamine and 10 mM HEPES, with pH set to 7.4 using HCl. To test for Mg2+-induced currents, the extracellular perfusion solution changed to a Mg2+-supplemented solution containing 80 mM N-methyl-d-glucamine, 20 mM MgCl2 and 10 mM HEPES, with pH set to 7.4 using HCl. The content of the Mg2+-free and Mg2+-supplemented solutions was guided by a previous study41. The Mg2+-free or Mg2+-supplemented solution was continuously perfused through the recording chamber (0.5 ml min−1) using a pump (Harvard Apparatus MP II, CMA Microdialysis).

Electrophysiological analysis was performed in GraphPad Prism 10 (GraphPad Software). The peak amplitude of the inward current was quantified by subtracting the stable basal current during initial perfusion with Mg2+-free solution (likely caused by a minor unspecific leak upon penetrating the oocyte with the two electrodes) from the peak current during perfusion with Mg2+-supplemented solution. The extent of current decay during perfusion with Mg2+-supplemented solution was quantified by calculating the difference in current amplitude between the peak current and the current amplitude at the end of the 2-min period that Mg2+ was supplied (analysis details in Supplementary Fig. 2). The ability of 1 mM cobalt hexammine to reduce the inward current was determined by calculating the difference in current amplitude without and with 1 mM cobalt hexammine added to the Mg2+-supplemented solution. Only oocytes with a basal and stable leak current < 200 nA were included for analysis.

Statistical analysis was performed in GraphPad Prism 10 (GraphPad Software). Data are shown as the mean ± s.e.m. Statistics involving several groups were calculated using a one-way analysis of variance (ANOVA) followed by a Dunnett’s multiple-comparisons test to compare the data for mutants and the WT. Statistics for the pharmacological effects of cobalt hexammine were calculated using a paired t-test. A P value < 0.05 was considered significant. In Fig. 5d, Ipeak denotes the peak current amplitude subsequent to the perfusion of Mg2+-containing solution (as described above). ΔIamp (%) denotes the spontaneous current decay during the perfusion of Mg2+-containing solution, which was quantified as the difference in current amplitude between the peak current and the remaining current at the end of the 2-min period of Mg2+ perfusion (as described above). For Ipeak, n = 19 (WT), 5 (S328A;T329A), 5 (S396A;397A) and 7 (E374A;E378A). For ΔIamp (%), n = 12 (WT), 5 (S328A;T329A), 5 (S396A;397A) and 12 (E374A;E378A). Note that GraphPad plots overlapping individual values side-by-side, for clarity.

ITC

ITC experiments were performed on a MicroCal PEAQ ITC instrument (Malvern Panalytical) at a temperature of 318.1 ± 0.1 K by titrating Mg2+ at a concentration of 50 ± 1 mM (25 ± 1 mM) into the cell (cell volume: 200 µl), containing the protein at a monomer concentration of 25 ± 2 µM (determined by ultraviolet absorption at 280 nm using an extinction coefficient of 65,780 M1 cm1). The principles of the ITC method are described elsewhere67. The instrument conditions were a rotation of 750 rpm and differential power of 5 µcal s−1. The GFP-fused CtMrs2 proteins in the form of WT and the four mutants (E374R, S328A;T329A, S396A;S397A and E374A;E378A) were used in the experiments. The protein and Mg2+ solutions (MgCl2) were prepared to achieve exact buffer-matching conditions with the two solutions having identical concentrations of all solutes except for the protein, Cl and Mg2+. Control experiments were performed before each experiment session by injecting 50 mM (25 mM) MgCl2, 50 mM HEPES pH 8.0, 150 mM NaCl, 10% (v/v) glycerol and 0.03% (w/v) DDM into the buffer solution of 50 mM HEPES pH 8.0, 150 mM NaCl, 10% (v/v) glycerol and 0.03% (w/v) DDM. Initially, a Mg2+ concentration of 1,000 µM was titrated into 15 µM WT CtMrs2 to test for high-affinity binding. The heat produced under these conditions was too small to be reliably quantified, with a δ(ΔH) between the first and last injection of only ~0.5 kJ mol−1. The Mg2+ concentration was consequentially increased fiftyfold to 50 mM to match the conditions of the protease digest assay and the electrophysiology measurements. For all ITC experiments, 18 or 19 injections of 2 µl of Mg2+ were used, with duplicates for each complex except for the WT where one experiment at 50 mM and one at 25 mM Mg2+ were run. The time between injections was set to 4 min to optimize the peak integration and the error analysis was performed in NITPIC to achieve individual error bars assigned to each injection54,68. Before the peak integration, the control was subtracted.

Determination Mg2+-binding stoichiometry using ICP-MS

The protein samples were purified in DDM detergent as outlined above. For the Mg2+-bound WT sample, 2 mM Mg2+ was present in all the buffers except the final size-exclusion purification step to remove excess Mg2+. The two mutant samples (S328A;T329A and S396A;S397A) were prepared similarly to the WT sample. To generate the EDTA-treated sample, the protein was purified as mentioned above for the open state and further purified on a HiTrap desalting column to remove excess EDTA for ICP-MS analysis. Magnesium content (24Mg, 25Mg and 26Mg isotopes) was quantified by ICP-MS (Agilent 7900, equipped with an autosampler) after digesting the CtMrs2 samples (CtMrs2 monomer concentration = 12–17 µM) in 67% HNO3 (v/v) for 16 h at 85 °C and subsequently diluting each sample to a final concentration of 1% HNO3 (v/v) using ultrapure H2O. Final magnesium concentrations were calculated accounting for dilution (average of five technical replicates) before the determination of experimental Mg-to-protein ratios. Protein concentration was determined using a Bradford assay with BSA as the standard.

Yeast strains used in this study

MATa ura3Δ0 leu2Δ0 his3Δ1 met15Δ0

EUROSCARF

BY4741(WT)

BY4741 mrs2::hphNT1

This paper

mrs2Δ

  1. Italic formatting represents gene replacement, deletion or mutation.

Expression constructs used in this study

p426-prADH1-HA-Mrs2

This paper

Mrs2FL

p426-prADH1-HA-Mrs2-E341K/E342K

This paper

Mrs2E341K;E342K

p426-prADH1-HA-Mrs2-GMN333-335AAA

This paper

Mrs2G333A;M334A;N335A

p426-prADH1-HA-Mrs2-S326A

This paper

Mrs2S326A

p426-prADH1-HA-Mrs2-T319A

This paper

Mrs2T319A

p426-prADH1-HA-Mrs2-M309A

This paper

Mrs2M309A

p426-prADH1-HA-Mrs2-RN305-306AA

This paper

Mrs2R305A;N306A

p426-prADH1-HA-Mrs2-D302A

This paper

Mrs2D302A

Reporting summary

Further information on research design is available in the Nature Portfolio Reporting Summary linked to this article.